Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acupuncture Combined With Mesalazine for Mild-to-Moderate Active Ulcerative Colitis
NCT07389824Recruiting
- Start
- Feb 2026
- Primary completion
- Sep 2027
- Countries
- 1
01
Overview
Randomised trial in ulcerative colitis (UC) (2 arms). Primary endpoint: Clinical remission rate. Started Feb 2026; status: recruiting.
02
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT07389824.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07389824.